Traws Pharma Inc share price logo

Traws Pharma Inc

NASDAQ: TRAW

Small Cap

$1.53

+0.02

(+1.66%)

Live

as on

Traws Pharma Inc Stock Performance

as on May 6, 2026 at 3:00 am IST

  • Day's Low

    Day's High

    $1.48
    $1.56
    downward going graph

    3.27%

    Downside

    1.96%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.97
    $3.27
    downward going graph

    36.60%

    Downside

    113.40%

    Upside

    downward going graph

Traws Pharma Inc share price movements today

Previous Close
$1.51
Open
$1.48
Volume
150.7K
Day's Low - High
$1.48 - $1.56
52 Week Low - High
$0.97 - $3.27

Traws Pharma Inc Historical Returns

1 Month Return
-7.93 %
3 Month Return
-12.21 %
1 Year Return
+ 0.67 %
3 Year Return
0 %
5 Year Return
0 %

Traws Pharma Inc Stock Fundamentals & Key Indicators

Check Traws Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$15.3M

EPS (TTM)

-2.93

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

1.8

Industry PE ratio

-4.262286995515695

PEG Ratio

0

EBITDA

-17.8M

Revenue (TTM)

2.8M

Profit Margin

328.67%

Return On Equity TTM

-1059.63%

Traws Pharma Inc Stock Valuation

Track how Traws Pharma Inc P/E has moved over time to understand its valuation trends.

Traws Pharma Inc in the last 5 years

  • Overview

  • Trends

Lowest (-2.89x)

June 30, 2024

Industry (-4.26x)

May 5, 2026

Today (1.80x)

May 5, 2026

Highest (0.44x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 1.80x

Traws Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Traws Pharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Traws Pharma Inc image
Traws Pharma Inc
BUY$15.3MNA1.8328.67%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.8B124.56%74.6712.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.3B100.99%27.732.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.0BNA118.865.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.5B47.01%17.1229.65%

Stock Returns calculator for Traws Pharma Inc Stock including INR - Dollar returns

The Traws Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Traws Pharma Inc investment value today

Current value as on today

₹1,15,293

Returns

₹15,293

(+15.29%)

Returns from Traws Pharma Inc Stock

₹2,000 (+2%)

Dollar Impact

₹13,293 (+13.29%)

Analyst Recommendation on Traws Pharma Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Traws Pharma Inc. Average target price of $5.5

Traws Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Traws Pharma Inc.

What analysts predicted

72.18%UPSIDE

Target Price

$5.5

Current Price

$1.53

Analyzed by

8 Analysts

Target

$5.50

Traws Pharma Inc target price $5.5, a slight upside of 72.18% compared to current price of $1.53. According to 8 analysts rating.

Traws Pharma Inc Stock’s Investor Sentiment and Interest

Search interest for Traws Pharma Inc Stock has increased by 318% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:318% versus previous 30 day period

Traws Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
0
0
0
2
-
-
0
Gross Profit
0
0
0
0
0
0
2
-
-
0
Operating Income
-9
-5
-5
-8
-8
-5
-1
-4
-7
-4
EBITDA
-9
-5
-5
-8
-8
21
-1
-3
-
-4
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-8
-4
-4
-8
-8
21
0
-3
-7
-3
Income Tax Expense
0
0
-
-
-
-
-
-
-
-
Net Income
-8
-4
-4
-8
-8
15
0
-3
-7
-3
Net Profit Margin
-7896.46%
-8898.21%
-8898.21%
-14868.42%
-14868.42%
26461.40%
-33.48%
0.00%
0.00%
-5324.56%

Traws Pharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
5
0
1
2
0
0
0
0
0
2
Gross Profit
5
0
1
2
0
0
0
0
0
2
Operating Income
-23
-25
-23
-21
-24
-16
-19
-20
-49
-17
EBITDA
-19
-23
-20
-21
-24
-16
-19
-20
-166
-17
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
0
0
0
0
0
0
Income Before Tax
-19
-24
-20
-21
-25
-16
-18
-18
-166
9
Income Tax Expense
0
0
0
0
0
0
0
0
-
-
Net Income
-19
-24
-20
-21
-25
-16
-18
-18
-54
9
Net Profit Margin
-354.62%
-3061.25%
-1675.33%
-985.02%
-10890.48%
-7151.77%
-8391.15%
-8384.07%
-24192.04%
328.67%

Traws Pharma Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-4
-123
-8
81
21
0
-3
-7
9
Operating Cash Flow
-4
-9
-11
-4
-5
-5
-4
-2
-4
Investing Cash Flow
-
-3
-
-
-
-
-2
-
-2
Financing Cash Flow
-
13
-
19
0
3
0
0
0
Change in Cash
-4
0
-11
15
-5
-2
-6
-2
-6

Traws Pharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-20
-21
-25
-16
-18
-18
-54
9
Operating Cash Flow
-23
-22
-20
-23
-19
-16
-17
-29
-18
Investing Cash Flow
-
-
0
0
-
-
0
-3
-2
Financing Cash Flow
6
35
26
19
55
-
-
33
3
Change in Cash
-17
12
5
-3
36
-16
-17
0
-17

Traws Pharma Inc News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 06:03 PM

    -

    Traws Pharma reports Q3 2025 results, highlighting revenue growth and advancements in clinical programs for respiratory viral diseases.

Insights on Traws Pharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, TRAW stock has moved up by 24.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -7.44M → -3.03M (in $), with an average increase of 145.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 17.5% return, outperforming this stock by 16.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.73M → 57.0K (in $), with an average decrease of 97.9% per quarter

About Traws Pharma Inc

Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are designed to address treatment resistance, such as TRX01 (Ratutrelvir), an inhibitor in development for the treatment of COVID-19; and Tivoxavir marboxil, an endonuclease inhibitor in development for the treatment of bird flu and seasonal influenza. It is also developing narazaciclib, a multi-targeted kinase inhibitor in solid tumors and hematological malignancies as a single agent or in combination with other anti-cancer therapies; and rigosertib, which is administered alone or in combination for investigation in various cancers. It has a license agreement with SymBio Pharmaceuticals Limited, Pint International SA, Viriom, Inc., and Temple University. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.
OrganisationTraws Pharma Inc
Headquarters12 Penns Trail, Newtown, PA, United States, 18940
IndustryBiotechnology
CEODr. Iain D. Dukes DPHIL, M.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Traws Pharma Inc

Name

Title

Dr. Charles David Pauza Ph.D.

Chief Scientific Officer of Virology

Dr. Victor Mandia Moyo M.D.

Chief Medical Officer of Oncology

Dr. Iain D. Dukes DPHIL, M.A., Ph.D.

CEO, Secretary & Director

Mr. Charles Parker

Chief Financial Officer

Dr. Nikolay Savchuk Ph.D.

COO & Director

Dr. Robert R. Redfield M.D.

Chief Medical Officer

FAQs

What is Traws Pharma Inc share price today?

Traws Pharma Inc share price today is $1.53 as on . Traws Pharma Inc share today touched a day high of $1.56 and a low of $1.48.

What is the 52 week high and 52 week low for Traws Pharma Inc share?

Traws Pharma Inc share touched a 52 week high of $3.27 on and a 52 week low of $0.97 on . Traws Pharma Inc stock price today i.e. is trending at $1.53,which is 53.14% down from its 52 week high and 57.73% up from its 52 week low.

What is Traws Pharma Inc's market capitalisation today?

Traws Pharma Inc market capitalisation is $0.00T as on .

How to invest in Traws Pharma Inc Stock (TRAW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Traws Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Traws Pharma Inc Shares that will get you 0.9804 shares as per Traws Pharma Inc share price of $1.53 per share as on May 5, 2026 at 9:30 pm IST.

What is the minimum amount required to buy Traws Pharma Inc Stock (TRAW) from India?

Indian investors can start investing in Traws Pharma Inc (TRAW) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Traws Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Traws Pharma Inc share’s latest price of $1.53 as on May 5, 2026 at 9:30 pm IST, you will get 6.5359 shares of Traws Pharma Inc. Learn more about fractional shares .